Article

Metabolomic biomarkers from patients with Barth syndrome treated with elamipretide: insights from the TAZPOWER study

2020-11-23

Abstract excerpt

<h4>Background</h4> Barth syndrome is an inherited disorder that results from pathogenic mutations in TAZ , the gene responsible for encoding tafazzin, an enzyme that remodels the mitochondrial phospholipid cardiolipin. Barth syndrome is characterized by heart and skeletal muscle myopathy, growth delay, and neutropenia among other features. The TAZPOWER clinical trial investigated the effects of the mitochondria-t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: adc07ab3-ecd1-5774-9dd3-f5aec25bcbbc
DOI: 10.1101/2020.11.20.20235580

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Metabolomic biomarkers from patients with Barth syndrome treated with elamipretide: insights from the TAZPOWER studyDOI 10.1101/2020.11.20.20235580Read

Pharmacogenomic considerations in the treatment of the pediatric cardiomyopathy called Barth syndrome.Semantic proximity Read

Temporal evolution of the heart failure phenotype in Barth syndrome and treatment with elamipretide.Semantic proximity Read

Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.Semantic proximity Read

New targets for monitoring and therapy in Barth syndrome.Semantic proximity Read

Metabolomics Reveals New Mechanisms for Pathogenesis in Barth Syndrome and Introduces Novel Roles for Cardiolipin in Cellular Function.Semantic proximity Read

Use of Elamipretide in Patients Assigned Treatment in the Compassionate Use Program: Case Series in Four Rare Orphan DiseasesSemantic proximity Read

Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.Semantic proximity Read

Integrated Multi-Omics Mapping of Mitochondrial Dysfunction and Substrate Preference in Barth Syndrome Cardiac TissueSemantic proximity Read

Biochemical phenotyping unravels novel metabolic abnormalities and potential biomarkers associated with treatment of GLUT1 deficiency with ketogenic diet.Semantic proximity Read

Barth syndrome cellular models have dysregulated respiratory chain complex I and mitochondrial quality control due to abnormal cardiolipinSemantic proximity Read

Clinical presentation and natural history of Barth Syndrome: An overview.Semantic proximity Read

Long-chain fatty acid oxidation and respiratory complex I deficiencies distinguish Barth Syndrome from idiopathic pediatric cardiomyopathy.Semantic proximity Read